Russell Ellison
President presso Rockwell Transportation, Inc.
Patrimonio netto: 1 819 $ in data 31/03/2024
Profilo
Russell H.
Ellison currently works at Rockwell Transportation, Inc., as President & Director.
Dr. Ellison also formerly worked at Rockwell Medical, Inc., as President, Chief Executive Officer & Director from 2020 to 2022, Ventrus Biosciences, Inc., as Chairman, Chief Executive Officer & President from 2013 to 2014, Promedior, Inc., as Chief Executive Officer in 2018, Bond Biosciences, Inc., as President & Chief Executive Officer from 2016 to 2018, CorMedix, Inc., as Chairman, Cougar Biotechnology, Inc., as Director in 2009, Mt.
Cook Pharma, Inc., as Director, ProSanos Corp., as Independent Director, Janssen Oncology, Inc., as Director, Torreya Partners LLC, as Executive Director from 2015 to 2018, Assembly Biosciences, Inc., as Director in 2015, Paramount BioCapital Asset Management, Inc., as Executive Vice President, Hoffmann-La Roche, Inc., as Chief Medical Officer & VP-Medical Affairs from 1997 to 2002, FibroGen, Inc., as Vice President-Clinical Development from 2005 to 2007, Paramount BioSciences LLC, as Executive Vice President from 2007 to 2010, Sanofi-Synthelabo, Inc., as Chief Medical Officer & VP-Medical Affairs from 2002 to 2004, and Alameda Consulting LLC, as Managing Partner from 2015 to 2018.
Dr. Ellison received his doctorate degree from the University of British Columbia and graduate degree from London School of Hygiene & Tropical Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ROCKWELL MEDICAL, INC.
0.00% | 24/03/2023 | 1 096 ( 0.00% ) | 1 819 $ | 31/03/2024 |
Posizioni attive di Russell Ellison
| Società | Posizione | Inizio |
|---|---|---|
Rockwell Transportation, Inc.
 Rockwell Transportation, Inc. Air Freight/CouriersTransportation Rockwell Transportation, Inc. engages in arrangement of freight and cargo transportation services. The company is headquartered in Wixom, MI. | President | - |
Precedenti posizioni note di Russell Ellison
| Società | Posizione | Fine |
|---|---|---|
| ROCKWELL MEDICAL, INC. | Chief Executive Officer | 30/06/2022 |
Promedior, Inc.
 Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Chief Executive Officer | 01/12/2018 |
Torreya Partners LLC
 Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Director/Board Member | 01/05/2018 |
Bond Biosciences, Inc.
 Bond Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Bond Biosciences, Inc. engages in healthcare business. It focuses on small developing molecule based therapeutics for preventing iron absorption. The company is headquartered in New York, NY. | Chief Executive Officer | 01/05/2018 |
| Alameda Consulting LLC | Corporate Officer/Principal | 01/05/2018 |
Formazione di Russell Ellison
| University of British Columbia | Doctorate Degree |
| London School of Hygiene & Tropical Medicine | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| CORMEDIX INC. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| Aziende private | 14 |
|---|---|
Paramount BioCapital Asset Management, Inc.
 Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | Finance |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Health Technology |
Mt. Cook Pharma, Inc.
 Mt. Cook Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mt. Cook Pharma, Inc. provides treatment for urological diseases. It offers services to overactive bladder, lower urinary symptoms, and interstitial cystitis diseases. The company was headquartered in Princeton, NJ. | Health Technology |
Ventrus Biosciences, Inc.
 Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ventrus Biosciences, Inc. is a development stage specialty pharmaceutical company engages in development of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoidal disease, anal fissures, and fecal incontinence. Its major pharmaceutical progress made in the gastrointestinal therapeutic areas of gastroesophageal reflux, peptic ulcer disease, and inflammatory bowel disease. Ventrus Biosciences products includes VEN 307 (topical diltiazem), is intended to treat pain associated with anal fissures and VEN 308 (topical phenylephrine), is intended to treat fecal incontinence. The company was founded on October 10, 2005 and is headquartered in New York, NY. | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Promedior, Inc.
Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Health Technology |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
| Sanofi-Synthelabo, Inc. | Health Technology |
ProSanos Corp.
 ProSanos Corp. Medical/Nursing ServicesHealth Services ProSanos Corp. develops and provides healthcare solutions for the pharmaceutical and biotechnology industries. The company was founded by Jonathan A. Morris and Michael N. Liebman in 2000 and is headquartered in Harrisburg, PA. | Health Services |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Finance |
Rockwell Transportation, Inc.
Rockwell Transportation, Inc. Air Freight/CouriersTransportation Rockwell Transportation, Inc. engages in arrangement of freight and cargo transportation services. The company is headquartered in Wixom, MI. | Transportation |
Bond Biosciences, Inc.
Bond Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Bond Biosciences, Inc. engages in healthcare business. It focuses on small developing molecule based therapeutics for preventing iron absorption. The company is headquartered in New York, NY. | Health Technology |
| Alameda Consulting LLC | |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Health Technology |
- Borsa valori
- Insiders
- Russell Ellison
